These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32206479)

  • 21. Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.
    Choudhary P; Olsen BS; Conget I; Welsh JB; Vorrink L; Shin JJ
    Diabetes Technol Ther; 2016 May; 18(5):288-91. PubMed ID: 26907513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System.
    Nishihama K; Eguchi K; Maki K; Okano Y; Tanaka S; Inoue C; Uchida A; Uemura M; Suzuki T; Yasuma T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    Am J Case Rep; 2021 Jan; 22():e928090. PubMed ID: 33462171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term sensor-augmented pump therapy for neonatal diabetes mellitus: a case series.
    Fukuda Y; Ishii A; Kamasaki H; Fusagawa S; Terada K; Igarashi L; Kobayashi M; Suzuki S; Tsugawa T
    Clin Pediatr Endocrinol; 2022; 31(3):178-184. PubMed ID: 35928380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes.
    Matsuoka A; Hirota Y; Urai S; Hamaguchi T; Takeuchi T; Miura H; Suematsu N; So A; Nakamura T; Komada H; Okada Y; Sakaguchi K; Ogawa W
    Diabetol Int; 2018 Jul; 9(3):201-207. PubMed ID: 30603368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensor augmented pump may improve awareness of hypoglycemia and quality of life in Japanese patients with type 1 diabetes mellitus.
    Takagi S; Miura J; Shimura K; Hoshina S; Tsuchida Y; Takita M; Mochizuki S; Shen Z; Asanuma T; Takaike H; Babazono T
    Diabetol Int; 2022 Jan; 13(1):280-287. PubMed ID: 35059264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 Diabetes.
    Joubert M; Briant AR; Kessler L; Fall-Mostaine F; Dubois S; Guerci B; Schoumacker-Ley L; Reznik Y; Parienti JJ
    Diabetes Ther; 2022 Sep; 13(9):1645-1657. PubMed ID: 35913656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
    Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
    Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized Trial.
    Habteab A; Castañeda J; de Valk H; Choudhary P; Bosi E; Lablanche S; de Portu S; Da Silva J; Vorrink-de Groot L; Shin J; Cohen O
    Diabetes Technol Ther; 2020 Sep; 22(9):681-685. PubMed ID: 32412858
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-Month Glycemic Control with a Hybrid Closed-Loop System in Type 1 Diabetes Patients in a Latin American Country.
    Proietti A; Raggio M; Paz M; Rubin G; Kabakian M; Saleme A; Grosembacher L
    Diabetes Technol Ther; 2022 Mar; 24(3):220-226. PubMed ID: 34668782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Viñals C; Quirós C; Giménez M; Conget I
    Diabetes Ther; 2019 Jun; 10(3):929-936. PubMed ID: 30900146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy.
    Gomez AM; Gomez C; Aschner P; Veloza A; Muñoz O; Rubio C; Vallejo S
    J Diabetes Sci Technol; 2015 May; 9(3):619-24. PubMed ID: 25555390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.